These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 32653600)
81. Authors' Reply to Yajing Du's Letter to the Editor on "Biologically Effective Dose in Stereotactic Body Radiotherapy and Survival for Patients With Early-Stage NSCLC". Moreno AC; Lin SH J Thorac Oncol; 2020 Oct; 15(10):e166-e168. PubMed ID: 32981605 [No Abstract] [Full Text] [Related]
82. Estimated Risk Level of Unified Stereotactic Body Radiation Therapy Dose Tolerance Limits for Spinal Cord. Grimm J; Sahgal A; Soltys SG; Luxton G; Patel A; Herbert S; Xue J; Ma L; Yorke E; Adler JR; Gibbs IC Semin Radiat Oncol; 2016 Apr; 26(2):165-71. PubMed ID: 27000514 [TBL] [Abstract][Full Text] [Related]
83. MRI-Related Geometric Distortions in Stereotactic Radiotherapy Treatment Planning: Evaluation and Dosimetric Impact. Pappas EP; Alshanqity M; Moutsatsos A; Lababidi H; Alsafi K; Georgiou K; Karaiskos P; Georgiou E Technol Cancer Res Treat; 2017 Dec; 16(6):1120-1129. PubMed ID: 29332453 [TBL] [Abstract][Full Text] [Related]
84. The correct usage of the new radiation oncology codes. 77395--3-dimensional simulation; 77419--conformal weekly radiation therapy treatment management; 77432--stereotactic treatment management. Bogardus C Adm Radiol; 1994 Sep; 13(9):53-6. PubMed ID: 10138361 [TBL] [Abstract][Full Text] [Related]
85. The influence of the α/β ratio on treatment time iso-effect relationships in the central nervous system. Jones B; Klinge T; Hopewell JW Int J Radiat Biol; 2020 Jul; 96(7):903-909. PubMed ID: 32243225 [No Abstract] [Full Text] [Related]
86. Stereotactic body radiation therapy for lung cancer: achievements and perspectives. Hiraoka M; Matsuo Y; Takayama K Jpn J Clin Oncol; 2010 Sep; 40(9):846-54. PubMed ID: 20670962 [TBL] [Abstract][Full Text] [Related]
87. Letter to the Editor of Radiotherapy and Oncology regarding the paper entitled "Prospective Data Registration and Clinical Trials for Particle Therapy" by Langendijk et al. Laprie A; Bernier V; Carrie C; Radiother Oncol; 2019 Jan; 130():193. PubMed ID: 30360997 [No Abstract] [Full Text] [Related]
91. Letter to the editor in response to German et al. Stereotactic radiosurgery for vestibular schwannomas: a survey of current practice patterns of neurotologists. Francis HW; Rigamonti D Otol Neurotol; 2012 Jun; 33(4):686-7. PubMed ID: 22569144 [No Abstract] [Full Text] [Related]
92. Recent advances in radiation therapy for head and neck cancer. Bangalore M; Matthews S; Suntharalingam M ORL J Otorhinolaryngol Relat Spec; 2007; 69(1):1-12. PubMed ID: 17085946 [TBL] [Abstract][Full Text] [Related]
93. Treatment and prophylaxis for brain metastases from non-small cell lung cancer: whole brain radiation treatment versus stereotactic radiosurgery. Ferrarese F; Baggio V; Zorat PL; Fiore D Ann Oncol; 2006 Mar; 17 Suppl 2():ii71-72. PubMed ID: 16608990 [No Abstract] [Full Text] [Related]
94. Dose fall-off patterns with volumetric modulated arc therapy and three-dimensional conformal radiotherapy including the "organ at risk" effect. Experience of linear accelerator-based frameless radiosurgery from a single institution. Munshi A; Sarkar B; Roy S; Ganesh T; Mohanti BK Cancer Radiother; 2019 Apr; 23(2):138-146. PubMed ID: 30797691 [TBL] [Abstract][Full Text] [Related]
95. Definitive and Adjuvant Radiotherapy in Locally Advanced Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline. Bezjak A; Temin S; Franklin G; Giaccone G; Govindan R; Johnson ML; Rimner A; Schneider BJ; Strawn J; Azzoli CG J Clin Oncol; 2015 Jun; 33(18):2100-5. PubMed ID: 25944914 [TBL] [Abstract][Full Text] [Related]
96. Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protocol. Souhami L; Seiferheld W; Brachman D; Podgorsak EB; Werner-Wasik M; Lustig R; Schultz CJ; Sause W; Okunieff P; Buckner J; Zamorano L; Mehta MP; Curran WJ Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):853-60. PubMed ID: 15465203 [TBL] [Abstract][Full Text] [Related]
97. Letter to the editor concerning Valstar et al., [Radiother Oncol 2020 Sep 23;S0167-8140(20)30809-4. doi: 10.1016/j.radonc.2020.09.034]. Bikker FJ; Vissink A Radiother Oncol; 2021 Jan; 154():318. PubMed ID: 33309998 [No Abstract] [Full Text] [Related]
98. [Cardio-oncology: radiation dose to the heart during thoracic radiotherapy]. Duma MN; Wittig A Strahlenther Onkol; 2021 Mar; 197(3):261-263. PubMed ID: 33403441 [No Abstract] [Full Text] [Related]
99. Letter to the Editor regarding "The tubarial salivary glands: A potential new organ at risk for radiotherapy". Nascimento JJC; Ribeiro ECO; Silva-Neto EJ Radiother Oncol; 2021 Jan; 154():323. PubMed ID: 33310000 [No Abstract] [Full Text] [Related]
100. Letter to the Editor Regarding "Global Research Trends in Radiotherapy for Gliomas: A Systematic Bibliometric Analysis". Ho YS World Neurosurg; 2023 Feb; 170():251. PubMed ID: 36782411 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]